Hugh O. McDevitt

547 total citations
10 papers, 485 citations indexed

About

Hugh O. McDevitt is a scholar working on Immunology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hugh O. McDevitt has authored 10 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Genetics and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hugh O. McDevitt's work include T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (5 papers) and Diabetes and associated disorders (4 papers). Hugh O. McDevitt is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (5 papers) and Diabetes and associated disorders (4 papers). Hugh O. McDevitt collaborates with scholars based in United States, Sweden and United Kingdom. Hugh O. McDevitt's co-authors include Bernadette Scott, Lynn Ogata, Roland Liblau, David Lo, Andrew J. Caton, Cheng‐Chi Chao, Lars Klareskog, Minnie McMillan, J. Michael Cecka and Donal B. Murphy and has published in prestigious journals such as Nature, Immunity and Current Opinion in Immunology.

In The Last Decade

Hugh O. McDevitt

10 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugh O. McDevitt United States 8 359 163 57 55 55 10 485
Ji-Lao Fan United States 12 214 0.6× 60 0.4× 44 0.8× 116 2.1× 37 0.7× 16 520
E. Sickel Germany 4 326 0.9× 48 0.3× 22 0.4× 40 0.7× 19 0.3× 8 436
Kristi L. Rupert United States 6 282 0.8× 102 0.6× 11 0.2× 113 2.1× 31 0.6× 7 446
Rudolf C. Kuppers United States 10 275 0.8× 25 0.2× 19 0.3× 69 1.3× 67 1.2× 14 380
Fernando Díaz‐Espada Spain 12 263 0.7× 38 0.2× 15 0.3× 143 2.6× 84 1.5× 29 466
Thomas Østerbye Denmark 12 177 0.5× 94 0.6× 94 1.6× 127 2.3× 32 0.6× 21 374
Kurt Van Gunst United States 10 322 0.9× 245 1.5× 169 3.0× 69 1.3× 6 0.1× 11 503
P Billing United States 7 245 0.7× 76 0.5× 18 0.3× 137 2.5× 51 0.9× 8 448
Sarah C. Spencer United Kingdom 12 392 1.1× 53 0.3× 124 2.2× 71 1.3× 97 1.8× 18 539
Diana M. Cowen United Kingdom 7 150 0.4× 35 0.2× 90 1.6× 78 1.4× 38 0.7× 8 420

Countries citing papers authored by Hugh O. McDevitt

Since Specialization
Citations

This map shows the geographic impact of Hugh O. McDevitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh O. McDevitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh O. McDevitt more than expected).

Fields of papers citing papers by Hugh O. McDevitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh O. McDevitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh O. McDevitt. The network helps show where Hugh O. McDevitt may publish in the future.

Co-authorship network of co-authors of Hugh O. McDevitt

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh O. McDevitt. A scholar is included among the top collaborators of Hugh O. McDevitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh O. McDevitt. Hugh O. McDevitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
McDevitt, Hugh O.. (2001). The Role of MHC Class II Molecules in the Pathogenesis and Prevention of Type I Diabetes. Advances in experimental medicine and biology. 490. 59–66. 9 indexed citations
2.
McDevitt, Hugh O.. (2000). A new model for rheumatoid arthritis?. Arthritis Research. 2(2). 85–85. 8 indexed citations
3.
Klareskog, Lars & Hugh O. McDevitt. (1999). Rheumatoid arthritis and its animal models: the role of TNF-α and the possible absence of specific immune reactions. Current Opinion in Immunology. 11(6). 657–662. 42 indexed citations
4.
Chao, Cheng‐Chi & Hugh O. McDevitt. (1997). Identification of immunogenic epitopes of GAD 65 presented by A  g7 in non-obese diabetic mice. Immunogenetics. 46(1). 29–34. 58 indexed citations
5.
Scott, Bernadette, Roland Liblau, Lynn Ogata, et al.. (1994). A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1(1). 73–82. 300 indexed citations
6.
Smilek, Dawn E., Anand M. Gautam, Cecelia I. Pearson, Lawrence Steinman, & Hugh O. McDevitt. (1992). EAE: A Model for Immune Intervention with Synthetic Peptides. International Reviews of Immunology. 9(3). 223–230. 7 indexed citations
7.
Sinha, Animesh A., Robert B. Bell, Lawrence Steinman, & Hugh O. McDevitt. (1991). Oligonucleotide dot-blot analysis of HLA-DQβ alleles associated with multiple sclerosis. Journal of Neuroimmunology. 32(1). 61–65. 7 indexed citations
8.
Wraith, David C., Dawn E. Smilek, Dennis J. Mitchell, Lawrence Steinman, & Hugh O. McDevitt. (1990). T Cell Recognition in Experimental Autoimmune Encephalomyelitis: Prospects for Immune Intervention with Synthetic Peptides. International Reviews of Immunology. 6(1). 37–47. 8 indexed citations
9.
Adelman, Nancy, et al.. (1988). In Vivo Effects of Antibodies to Immune Response Gene Products. II. Suppression of Humoral Immune Responses with Monoclonal Anti-I-A Is Due to Suppressor Cells. International Reviews of Immunology. 3(4). 333–344. 1 indexed citations
10.
McMillan, Minnie, et al.. (1979). Peptide map analyses of murine Ia antigens of the I–E subregion using HPLC. Nature. 277(5698). 663–665. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026